Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO Statement on FDA and NIH Workforce Authorities Modernization Act

Mar 17 2016
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:

BIO Statement on Failure to Stop Patchwork of State GMO Labeling Laws

Mar 16 2016
The U.S. Senate was unable to advance a national solution to GMO food labeling.  It is essential for Senate leaders to continue working to reach a much-needed compromise over the coming days, as failure to move forward allows costly and confusing state-based measures such as Vermont’s GMO food labeling law to take effect in July.

2016 BIO International Convention Super Sessions Announced

Mar 10 2016
The Biotechnology Innovation Organization (BIO) announces the lineup for Super Sessions at the 2016 BIO International Convention, taking place in San Francisco’s Moscone Convention Center from June 6-9. Considered the global event for biotechnology, this year’s program is built around an “Imagine” theme.  Six Super Sessions will run during the course of the four day conference with topics on innovation and a look to the future.

BIO Applauds Advancement of Senate Biomedical Innovation Legislation

Mar 9 2016
BIO President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative...

BIO Statement on Proposed Part B Drug Payment Model

Mar 9 2016
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and ASPE Issue Briefs...

Dennis McGinn, Assistant Secretary of the Navy, to Deliver Remarks at the 2016 World Congress on Industrial Biotechnology

Mar 6 2016
The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations & Environment, will address biofuel and biorefining technology developers. McGinn will provide remarks during the “Overcoming Challenges to Biorefinery Scale Up” plenary scheduled for 4:30pm on Monday, April 18th.

BIO Brings UniFirst Uniform Services to BIO Members

Mar 2 2016
Washington, D.C. (March 2, 2016) – The Biotechnology Innovation Organization (BIO) has announced a new partnership with UniFirst Corporation (NYSE: UNF), an industry leader in the supply and servicing of uniforms, workwear, and facility products, to add managed uniform, protective clothing, and custom corporate image apparel programs to the BIO Business Solutions® offerings. As a supplier partner, UniFirst is now part of BIO’s exclusive Business Solutions ® program which is helping thousands of companies save on items they need to run a successful biotechnology enterprise.

BIO Applauds Advancement of GMO Labeling Bill

Mar 1 2016
Legislation enhances transparency, protects farmers BIO applauds bipartisan action today by the Senate Agriculture Committee to advance a biotech food labeling solution as an alternative to a costly and confusing patchwork of state laws.

BIO Applauds Advancement of Precision Medicine Initiative

Feb 26 2016
Washington, D.C. (February 26, 2016) – The Biotechnology Innovation Organization (BIO) Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s White House announcement of actions to accelerate the Precision Medicine Initiative:

BIO Congratulates Dr. Robert Califf on Confirmation as FDA Commissioner

Feb 24 2016
“BIO extends our congratulations to Dr. Califf on his confirmation as Commissioner of the FDA, a job that carries tremendous responsibility in protecting public health and advancing biotechnology innovation.